Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EKF DIAGNOSTICS HOLDINGS PLC Director's Dealing 2017

Mar 21, 2017

7617_rns_2017-03-21_5fc7f936-c2f4-4d5e-8260-7569c385abd1.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0971A

EKF Diagnostics Holdings PLC

21 March 2017

EKF Diagnostics Holdings plc

("EKF", the "Company")

PDMR dealing

EKF Diagnostics Holdings plc (AIM: EKF) announces that on 21 March 2017, the Company was notified that Harwood Capital LLP ("Harwood") acquired 8,000,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") as investment manager to North Atlantic Smaller Companies Investment Trust PLC ("NAIT"). Christopher Mills, the Company's Non-Executive Chairman, is a partner and Chief Investment Officer of Harwood and a director and shareholder in NAIT.

Following the above transaction, which was completed on 20 March 2017 at a price of 19.5p pence per share, NAIT's interest is now in 98,000,000 Ordinary Shares, representing 21.12% of the Company's issued share capital. The interests of Oryx International Growth Fund Limited ("Oryx", whose investment adviser is Harwood) remains as previously disclosed in 40,000,000 Ordinary Shares, representing 8.62% of the Company's issued share capital. Mr Mills is also a director and shareholder in Oryx.

The total indirect beneficial interest of Mr Mills is, following the above transaction, therefore now in 138,000,000 Ordinary Shares, representing 29.73% of the Company's issued share capital.

EKF Diagnostics Holdings plc www.ekfdiagnostics.com
Christopher Mills, Non-Executive Chairman Tel: 029 2071 0570
Julian Baines, CEO
Richard Evans, FD & COO
N+1 Singer (Nomad & Broker) Tel: 020 7496 3000
Alex Price / Shaun Dobson / Alex Laughton-Scott
Walbrook PR Limited Tel: 020 7933 8780 or [email protected]
Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / 07584 391 303

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Harwood Capital LLP, as investment manager to North Atlantic Smaller Companies Investment Trust PLC ("NAIT")

2

Reason for the notification

a)

Position/status

Christopher Mills, the Company's Non-Executive Chairman, is a partner and Chief Investment Officer of Harwood Capital LLP and a director and shareholder in NAIT

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

EKF Diagnostics Holdings plc

b)

LEI

213800DXTF3EAUK1AR05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1p each ("Ordinary Shares")

ISIN Code: GB0031509804

b)

Nature of the transaction

Acquisition of shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
19.5p 8,000,000

d)

Aggregated information

- Aggregated volume

- Price

n/a

e)

Date of the transaction

20 March 2017

f)

Place of the transaction

London Stock Exchange

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBXGDXUSDBGRB